alpha-Thalassaemia and hyperbilirubinaemia in G-6-PD-deficient newborns

Area of Science:

• Neonatal Medicine
• Hematology
• Medical Genetics

Background:

• Glucose-6-phosphate dehydrogenase (G-6-PD) deficiency is a common inherited red blood cell disorder.
• Hyperbilirubinaemia (jaundice) is a frequent complication in newborns, especially those with G-6-PD deficiency.
• Alpha-thalassaemia is another common genetic condition affecting haemoglobin production.

Purpose of the Study:

• To investigate the potential role of alpha-thalassaemia in the development of hyperbilirubinaemia among G-6-PD deficient newborns.
• To compare the incidence of jaundice in newborns with both G-6-PD deficiency and alpha-thalassaemia versus those with G-6-PD deficiency alone.

Main Methods:

• A cohort study involving 53 newborn infants with both G-6-PD deficiency and alpha-thalassaemia.
• Comparison with 120 newborn infants diagnosed solely with G-6-PD deficiency.
• Clinical assessment and monitoring for hyperbilirubinaemia in all studied infants.

Main Results:

• Of the 53 infants with both G-6-PD deficiency and alpha-thalassaemia, 12 (22.6%) developed hyperbilirubinaemia.
• Of the 120 infants with only G-6-PD deficiency, 32 (26.7%) showed signs of hyperbilirubinaemia.
• The incidence of hyperbilirubinaemia was not significantly different between the two groups.

Conclusions:

• Alpha-thalassaemia does not appear to be a significant risk factor for developing hyperbilirubinaemia in newborns with G-6-PD deficiency.
• The presence of alpha-thalassaemia does not exacerbate the risk of jaundice in G-6-PD deficient neonates.
• Further research may explore other genetic or environmental factors contributing to hyperbilirubinaemia in this population.